236
Views
0
CrossRef citations to date
0
Altmetric

References

  • Dahlhamer J, Lucas J, Zelaya C, Nahin R, Mackey S, DeBar L, Kerns R, Von Korff M, Porter L, Helmick C, et al. Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001–6.
  • National Diabetes Statistics Report. U.S.D.o.H.a.H. Services.Centers for Disease Control and Prevention 2020. https://www.cdc.gov/diabetes/data/statistics-report/index.html.
  • Szablewski L. Diabetes mellitus: influences on cancer risk. Diabetes Metab Res Rev. 2014;30(7):543–53. doi:10.1002/dmrr.2573.
  • Hassoon A, Bydon M, Kerezoudis P, Maloney PR, Rinaldo L, Yeh H-C. Chronic low-back pain in adult with diabetes: NHANES 2009-2010. J Diabetes Complicat. 2017;31(1):38–42. doi:10.1016/j.jdiacomp.2016.10.025.
  • Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–54. doi:10.2337/dc16-2042.
  • Piva SR, Susko AM, Khoja SS, Josbeno DA, et al. Links between osteoarthritis and diabetes: implications for management from a physical activity perspective. Clin Geriatr Med. 2015;31:67–87. viii.
  • Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, Callahan L, Copenhaver C, Dodge C, Felson D, et al. American College of Rheumatology/Arthritis Foundation Guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2020;72(2):149–62.
  • Qaseem A, Wilt TJ, Mclean RM, Forciea MA, for the Clinical Guidelines Committee of the American College of Physicians. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(7):514–30. doi:10.7326/M16-2367.
  • Guy GP, Jr., Zhang K, Bohm MK, Losby J, et al. Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep . 2017;66:697–704.
  • National Health and Nutrition Examination Survey available at https://www.cdc.gov/nchs/nhanes/index.htm.
  • Sinusas K. Osteoarthritis: diagnosis and treatment. Am Fam Physician. 2012;85:49–56.
  • Argoff CE, Cole BE, Fishbain DA, Irving GA. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc. 2006;81(4 Suppl):S3–S11.
  • Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell JW, et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011;76(20):1758–65. doi:10.1212/WNL.0b013e3182166ebe.
  • Tesfaye S, Vileikyte L, Rayman G, Sindrup SH, Perkins BA, Baconja M, Vinik AI, Boulton AJM, on behalf of The Toronto Expert Panel on Diabetic Neuropathy. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab. Res. Rev. 2011;27(7):629–38. doi:10.1002/dmrr.1225.
  • Lang L. Valdecoxib withdrawal leaves pain relief treatment gap. Gastroenterology. 2005;128(7):1769–70. doi:10.1053/j.gastro.2005.05.023.
  • Lyrica Package Insert 2004.
  • Lee B, Zhao W, Yang KC, Ahn YY, et al. Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007-2018. JAMA. 2021;4:e2036687.
  • Tsang A, Von Korff M, Lee S, Alonso J, Karam E, Angermeyer MC, Borges GLG, Bromet EJ, de Girolamo G, de Graaf R, et al. Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain. 2008;9(10):883–91. doi:10.1016/j.jpain.2008.05.005.
  • Musumeci G, Aiello F, Szychlinska M, Di Rosa M, Castrogiovanni P, Mobasheri A. Osteoarthritis in the XXIst century: risk factors and behaviours that influence disease onset and progression. Int J Mol Sci. 2015;16(12):6093–112. doi:10.3390/ijms16036093.
  • Kim YSKim N. Sex-Gender Differences in Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2018;24:544–58.
  • Pavlovic JM, Akcali D, Bolay H, Bernstein C, Maleki N. Sex-related influences in migraine. J Neurosci Res. 2017;95(1–2):587–93. doi:10.1002/jnr.23903.
  • Salganicoff A, Ranji U, Beamesderfer A, Kurani N. Women and health care in the early years of the ACA: key findings from the 2013 Kaiser Women’s Health Survey. Menlo Park: The Henry J. Kaiser Family Foundation; 2014.
  • Kurani N, Ranji U, Salganicoff A, Jankiewicz A, Rousseau D. Health care coverage and access for men, 2013-2015. JAMA. 2015;313(24):2414–doi:10.1001/jama.2015.6551.
  • National Ambulatory Medical Care Survey: 2018. National Summary Tables. https://www.cdc.gov/nchs/data/ahcd/namcs_summary/2018-namcs-web-tables-508.pdf.
  • Hales CM, Martin CQ. Prevalence of prescription pain medication use among adults: United States, 2015-2018. NCHS Data Brief. No. 369; 2020.
  • Table 39. Prescription drug use in the past 30 days, by sex, race and Hispanic origin, and age: United States, selected years 1988-1994 through 2015-2018. NCHS, National Health and Nutrition Examination Survey https://www.cdc.gov/nchs/data/hus/2019/039-508.pdf.
  • Non-steroidal anti-inflammatory drugs linked with heart failure in patients with diabetes. October 13, 2022. Available from: https://www.escardio.org/The-ESC/Press-Office/Press-releases/Non-steroidal-anti-inflammatory-drugs-linked-with-heart-failure-in-patients-with-diabetes.
  • Choosing Wisely Recommendations: Avoid nonsteroidal anti-inflammatory drugs (NSAIDs) in individuals with hypertension or heart failure or chronic kidney disease of all causes, including diabetes. 10/13/2022; https://www.aafp.org/pubs/afp/collections/choosing-wisely/36.html#:∼:text=Avoid%20nonsteroidal%20anti%2Dinflammatory%20drugs,of%20all%20causes%2C%20including%20diabetes.
  • Williams AW, Dwyer AC, Eddy AA, Fink JC, Jaber BL, Linas SL, Michael B, O’Hare AM, Schaefer HM, Shaffer RN, et al. Critical and honest conversations: the evidence behind the “Choosing Wisely” campaign recommendations by the American Society of Nephrology. Clin J Am Soc Nephrol. 2012;7(10):1664–72. doi:10.2215/CJN.04970512.
  • Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ. Cardiovascular risk factors for physician-diagnosed lumbar disc herniation. Spine J. 2006;6(6):684–91. doi:10.1016/j.spinee.2006.04.016.
  • Amin S, Niu J, Guermazi A, Grigoryan M, Hunter DJ, Clancy M, LaValley MP, Genant HK, Felson DT. Cigarette smoking and the risk for cartilage loss and knee pain in men with knee osteoarthritis. Ann Rheum Dis. 2007;66(1):18–22.
  • Videman T, Battié MC, Parent E, Gibbons LE, Vainio P, Kaprio J. Progression and determinants of quantitative magnetic resonance imaging measures of lumbar disc degeneration: a five-year follow-up of adult male monozygotic twins. Spine. 2008;33(13):1484–90. doi:10.1097/BRS.0b013e3181753bb1.
  • Xu B, Lin J. Characteristics and risk factors of rheumatoid arthritis in the United States: an NHANES analysis. PeerJ. 2017;5:e4035. doi:10.7717/peerj.4035.
  • Parkerson HA, Zvolensky MJ, Asmundson GJ. Understanding the relationship between smoking and pain. Expert Rev Neurother. 2013;13(12):1407–14. [Database] doi:10.1586/14737175.2013.859524.
  • Langabeer JR, Chambers KA, Cardenas-Turanzas M, Champagne-Langabeer T. County-level factors underlying opioid mortality in the United States. Subst Abus. 2022;43(1):76–82. doi:10.1080/08897077.2020.1740379.
  • Young-Wolff KC, Klebaner D, Weisner C, Von Korff M, Campbell CI. Smoking status and opioid-related problems and concerns among men and women on chronic opioid therapy. Clin J Pain. 2017;33(8):730–7. doi:10.1097/AJP.0000000000000461.
  • de Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, Rossing P, Zoungas S, Bakris G. Diabetes and hypertension: A position statement by the American Diabetes Association. Diabetes Care. 2017;40(9):1273–84. doi:10.2337/dci17-0026.
  • Hsu C-C, Wang H, Hsu Y-H, Chuang S-Y, Huang Y-W, Chang Y-K, Liu J-S, Hsiung CA, Tsai H-J. Use of nonsteroidal anti-inflammatory drugs and risk of chronic kidney disease in subjects with hypertension: Nationwide longitudinal cohort study. Hypertension. 2015;66(3):524–33. doi:10.1161/HYPERTENSIONAHA.114.05105.
  • Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–73. doi:10.1016/S1474-4422(14)70251-0.
  • Ziegler D. Painful diabetic neuropathy: treatment and future aspects. Diabetes Metab Res Rev. 2008;24(S1):S52–S57. doi:10.1002/dmrr.817.
  • Happich M, Schneider E, Boess FG, Wilhelm S, Schacht A, Birklein F, Ziegler D. Effectiveness of duloxetine compared with pregabalin and gabapentin in diabetic peripheral neuropathic pain: results from a German observational study. Clin J Pain. 2014;30(10):875–85. doi:10.1097/AJP.0000000000000057.
  • Pruitt Iii J, Moracho-Vilrriales C, Threatt T, Wagner S, Wu J, Romero-Sandoval EA. Identification, prevalence, and treatment of painful diabetic neuropathy in patients from a rural area in South Carolina. J Pain Res. 2017;10:833–43. doi:10.2147/JPR.S129139.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.